DLA
OGN icon

Douglas Lane & Associates’s Organon & Co OGN Stock Holding History

Douglas Lane & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Sell
180,663
-341,979
-65% -$4.09M 0.03% 147
2026
Q1 		$3.13M Buy
522,642
+36,897
+8% +$278K 0.05% 139
2025
Q4 		$3.48M Buy
485,745
+41,869
+9% +$331K 0.05% 135
2025
Q3 		$4.74M Buy
443,876
+127,924
+40% +$1.26M 0.07% 131
2025
Q2 		$3.06M Buy
315,952
+50,393
+19% +$520K 0.04% 135
2025
Q1 		$3.95M Sell
265,559
-5,279
-2% -$81.2K 0.06% 134
2024
Q4 		$4.04M Sell
270,838
-260,842
-49% -$4.25M 0.06% 133
2024
Q3 		$10.2M Buy
531,680
+3,792
+0.7% +$78.6K 0.14% 118
2024
Q2 		$10.9M Buy
527,888
+39,584
+8% +$787K 0.16% 111
2024
Q1 		$9.18M Buy
488,304
+127,529
+35% +$2.19M 0.13% 119
2023
Q4 		$5.2M Sell
360,775
-276,056
-43% -$3.76M 0.08% 125
2023
Q3 		$11.1M Buy
636,831
+85,218
+15% +$1.78M 0.19% 110
2023
Q2 		$11.5M Buy
551,613
+85,846
+18% +$1.87M 0.19% 107
2023
Q1 		$11M Sell
465,767
-958
-0.2% -$25.7K 0.18% 110
2022
Q4 		$13M Buy
466,725
+236,093
+102% +$6.04M 0.22% 107
2022
Q3 		$5.4M Buy
230,632
+29,893
+15% +$903K 0.1% 116
2022
Q2 		$6.78M Sell
200,739
-3,085
-2% -$108K 0.12% 114
2022
Q1 		$7.12M Buy
203,824
+26,298
+15% +$899K 0.1% 114
2021
Q4 		$5.41M Buy
177,526
+59,165
+50% +$1.93M 0.07% 117
2021
Q3 		$3.88M Buy
118,361
+63,249
+115% +$2.02M 0.06% 123
2021
Q2 		$1.67M Buy
+55,112
New +$1.81M 0.02% 140

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Douglas Lane & Associates's OGN Position: Q2 2026 in Review

Douglas Lane & Associates reduced its Organon & Co (OGN) stake by 65% in Q2 2026, selling an estimated $4.09M and leaving 180,663 shares worth $2.45M. The position accounts for 0.03% of the portfolio, ranked #147.

Douglas Lane & Associates first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $13M in Q4 2022. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Douglas Lane & Associates held 180,663 shares of Organon & Co worth $2.45M as of Q2 2026.
  • Douglas Lane & Associates sold 341,979 Organon & Co shares in Q2 2026, an estimated $4.09M.
  • Organon & Co made up 0.03% of Douglas Lane & Associates's portfolio in Q2 2026, its #147 holding.
  • Douglas Lane & Associates first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Douglas Lane & Associates's Organon & Co position peaked at $13M in Q4 2022.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.